Loading company…
TwoStep Therapeutics develops targeted therapies for solid tumors.
TwoStep Therapeutics develops targeted cancer therapies using cytotoxic payloads and immunotherapy. Its approach uses a modular peptide platform for multi-specific targeting. Founded in 2023, the company is based in California, US. In September 2026, it raised USD 62.5 million in Series A funding co-led by Insight Partners, Medical Excellence Capital, M Ventures, and Pfizer Venture Investments, with Stanford University, 2048 Ventures, and NFX participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in